Journey Medical Corporation (DERM)
USD 6.21
(2.99%)
USD 6.21
(2.99%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.21 USD | 87.57% |
| 2022 | -1.69 USD | 33.46% |
| 2021 | -2.54 USD | -893.75% |
| 2020 | 0.32 USD | 45.45% |
| 2019 | 0.22 USD | 104.17% |
| 2018 | -5.27 USD | 29.55% |
| 2017 | -7.48 USD | -177.04% |
| 2016 | -2.70 USD | 7.85% |
| 2015 | -2.93 USD | 40.93% |
| 2014 | -4.96 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.17 USD | 67.92% |
| 2024 Q1 | -0.53 USD | -381.82% |
| 2023 FY | - USD | 87.57% |
| 2023 Q3 | 0.91 USD | 297.83% |
| 2023 Q4 | -0.11 USD | -112.09% |
| 2023 Q1 | -0.56 USD | 6.67% |
| 2023 Q2 | -0.46 USD | 17.86% |
| 2022 Q2 | -0.43 USD | -440.2% |
| 2022 FY | - USD | 33.46% |
| 2022 Q1 | -0.08 USD | 95.15% |
| 2022 Q4 | -0.60 USD | -5.26% |
| 2022 Q3 | -0.57 USD | -32.56% |
| 2021 Q2 | -1.30 USD | -4536.86% |
| 2021 Q3 | -1.16 USD | 10.77% |
| 2021 Q4 | -1.64 USD | -41.38% |
| 2021 FY | - USD | -893.75% |
| 2021 Q1 | 0.03 USD | -80.47% |
| 2020 Q3 | 0.00 USD | -88.45% |
| 2020 FY | - USD | 45.45% |
| 2020 Q2 | 0.03 USD | -78.69% |
| 2020 Q4 | 0.15 USD | 4587.5% |
| 2020 Q1 | 0.13 USD | 0.0% |
| 2019 Q1 | -1.49 USD | 12.35% |
| 2019 FY | - USD | 104.17% |
| 2019 Q3 | -1.06 USD | -221.21% |
| 2019 Q2 | -0.33 USD | 77.85% |
| 2018 Q2 | -0.47 USD | 59.83% |
| 2018 Q3 | -1.58 USD | -236.17% |
| 2018 Q4 | -1.70 USD | -7.59% |
| 2018 FY | - USD | 29.55% |
| 2018 Q1 | -1.17 USD | -6.36% |
| 2017 Q1 | -0.58 USD | -286.67% |
| 2017 FY | - USD | -177.04% |
| 2017 Q4 | -1.10 USD | 68.84% |
| 2017 Q3 | -3.53 USD | -364.47% |
| 2017 Q2 | -0.76 USD | -31.03% |
| 2016 Q4 | -0.15 USD | 70.0% |
| 2016 Q3 | -0.50 USD | 54.95% |
| 2016 FY | - USD | 7.85% |
| 2016 Q2 | -1.11 USD | -98.21% |
| 2016 Q1 | -0.56 USD | 63.87% |
| 2015 Q1 | -0.28 USD | -115.38% |
| 2015 Q2 | -0.61 USD | -117.86% |
| 2015 Q3 | -0.32 USD | 47.54% |
| 2015 FY | - USD | 40.93% |
| 2015 Q4 | -1.55 USD | -384.38% |
| 2014 Q4 | -0.13 USD | 0.0% |
| 2014 FY | - USD | 0.0% |